title: Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses.
abstract: Human orosomucoid (ORM) is a major acute-phase plasma protein, encoded by 2 highly homologous genes, ORM1 and ORM2. Human ORM induction is assumed to be regulated by each proximal promoter region, where putative glucocorticoid responsive elements and CCAAT/enhancer binding protein (C/EBP)β binding sites are located. However, the details of the differential regulation of these genes remain unknown. To explore this, we assessed the role of the distal promoter region of each ORM in HeLa cells. Luciferase-reporter activities of full constructs, containing approximately 1.1 kbp (FULL), and those of deletion constructs, containing up to 188 bp region (DEL) upstream of the transcription start sites of ORM1 and ORM2 were compared under both basal and inducer-treated conditions. For ORM1 and ORM2 DEL constructs, significantly increased activities after dexamethasone (DEX) treatments (alone and combined with interleukin (IL)-1β) were observed. Significantly higher FULL construct activities than DEL construct activities were observed for ORM1 after IL-1β treatment, while those for ORM2 were significantly lower at basal level and after DEX treatments. Upon C/EBPβ overexpression, FULL construct activities were significantly higher than those of DEL constructs at basal level and after IL-1β treatment for ORM1, and at basal level and after inducer-treatments for ORM2. Higher transcription-induction activity in the distal promoter region was evident for ORM1 in the absence of C/EBPβ overexpression, and for ORM2 under C/EBPβ overexpression conditions. These findings suggest that the ORM distal promoter region differentially regulates expression of ORM genes at basal level and in acute phase responses.
authors.affiliation: National Institute of Health Sciences.
authors.forename: Kimie
authors.initials: K
authors.lastname: Sai
authors.forename: Kouichi
authors.initials: K
authors.lastname: Kurose
authors.forename: Tomoko
authors.initials: T
authors.lastname: Koizumi
authors.forename: Noriko
authors.initials: N
authors.lastname: Katori
authors.forename: Jun-ichi
authors.initials: J
authors.lastname: Sawada
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Matsumura
authors.forename: Nagahiro
authors.initials: N
authors.lastname: Saijo
authors.forename: Noboru
authors.initials: N
authors.lastname: Yamamoto
authors.forename: Tomohide
authors.initials: T
authors.lastname: Tamura
authors.forename: Haruhiro
authors.initials: H
authors.lastname: Okuda
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Saito
mesh_terms: D000210:Acute-Phase Reaction / Q000235:genetics*; D022782:CCAAT-Enhancer-Binding Protein-beta / Q000235:genetics / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology; D015870:Gene Expression; D005938:Glucocorticoids / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D053583:Interleukin-1beta / Q000494:pharmacology; D009961:Orosomucoid / Q000235:genetics* / Q000378:metabolism; D011401:Promoter Regions, Genetic; D015533:Transcriptional Activation
chemical_list: D022782:CCAAT-Enhancer-Binding Protein-beta; D005938:Glucocorticoids; D053583:Interleukin-1beta; D009961:Orosomucoid; D003907:Dexamethasone